BRCA1 and breast cancer: The analysis of long-term survivors revealed that high-dose chemotherapy is not a preferable option for non-selected BC cases, but may result in very prolonged responses and possibly even cure from the metastatic BC disease in carriers of germ-line BRCA1/2 mutations [86–88].